NM_006030.4:c.3291+10G>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006030.4(CACNA2D2):​c.3291+10G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.105 in 1,613,314 control chromosomes in the GnomAD database, including 9,431 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.082 ( 621 hom., cov: 32)
Exomes 𝑓: 0.11 ( 8810 hom. )

Consequence

CACNA2D2
NM_006030.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.11

Publications

14 publications found
Variant links:
Genes affected
CACNA2D2 (HGNC:1400): (calcium voltage-gated channel auxiliary subunit alpha2delta 2) Calcium channels mediate the entry of calcium ions into the cell upon membrane polarization. This gene encodes the alpha-2/delta subunit of the voltage-dependent calcium channel complex. The complex consists of the main channel-forming subunit alpha-1, and auxiliary subunits alpha-2/delta, beta, and gamma. The auxiliary subunits function in the assembly and membrane localization of the complex, and modulate calcium currents and channel activation/inactivation kinetics. The subunit encoded by this gene undergoes post-translational cleavage to yield the extracellular alpha2 peptide and a membrane-anchored delta polypeptide. This subunit is a receptor for the antiepileptic drug, gabapentin. Mutations in this gene are associated with early infantile epileptic encephalopathy. Single nucleotide polymorphisms in this gene are correlated with increased sensitivity to opioid drugs. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2014]
CACNA2D2 Gene-Disease associations (from GenCC):
  • cerebellar atrophy with seizures and variable developmental delay
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • complex neurodevelopmental disorder
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 3-50364878-C-G is Benign according to our data. Variant chr3-50364878-C-G is described in ClinVar as Benign. ClinVar VariationId is 585338.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.106 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006030.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA2D2
NM_006030.4
MANE Select
c.3291+10G>C
intron
N/ANP_006021.2
CACNA2D2
NM_001174051.3
c.3312+10G>C
intron
N/ANP_001167522.1
CACNA2D2
NM_001005505.3
c.3297+10G>C
intron
N/ANP_001005505.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA2D2
ENST00000424201.7
TSL:1 MANE Select
c.3291+10G>C
intron
N/AENSP00000390329.2
CACNA2D2
ENST00000423994.6
TSL:5
c.3321+10G>C
intron
N/AENSP00000407393.2
CACNA2D2
ENST00000479441.1
TSL:1
c.3312+10G>C
intron
N/AENSP00000418081.1

Frequencies

GnomAD3 genomes
AF:
0.0818
AC:
12452
AN:
152152
Hom.:
618
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0253
Gnomad AMI
AF:
0.189
Gnomad AMR
AF:
0.0742
Gnomad ASJ
AF:
0.0735
Gnomad EAS
AF:
0.0572
Gnomad SAS
AF:
0.0957
Gnomad FIN
AF:
0.141
Gnomad MID
AF:
0.111
Gnomad NFE
AF:
0.108
Gnomad OTH
AF:
0.0875
GnomAD2 exomes
AF:
0.0963
AC:
23966
AN:
248880
AF XY:
0.0989
show subpopulations
Gnomad AFR exome
AF:
0.0249
Gnomad AMR exome
AF:
0.0721
Gnomad ASJ exome
AF:
0.0749
Gnomad EAS exome
AF:
0.0567
Gnomad FIN exome
AF:
0.146
Gnomad NFE exome
AF:
0.111
Gnomad OTH exome
AF:
0.104
GnomAD4 exome
AF:
0.108
AC:
157503
AN:
1461044
Hom.:
8810
Cov.:
35
AF XY:
0.108
AC XY:
78687
AN XY:
726834
show subpopulations
African (AFR)
AF:
0.0221
AC:
740
AN:
33472
American (AMR)
AF:
0.0734
AC:
3284
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.0758
AC:
1981
AN:
26126
East Asian (EAS)
AF:
0.0792
AC:
3145
AN:
39690
South Asian (SAS)
AF:
0.104
AC:
8972
AN:
86256
European-Finnish (FIN)
AF:
0.145
AC:
7680
AN:
52796
Middle Eastern (MID)
AF:
0.102
AC:
589
AN:
5764
European-Non Finnish (NFE)
AF:
0.112
AC:
124772
AN:
1111856
Other (OTH)
AF:
0.105
AC:
6340
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
8523
17046
25568
34091
42614
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4532
9064
13596
18128
22660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0818
AC:
12456
AN:
152270
Hom.:
621
Cov.:
32
AF XY:
0.0822
AC XY:
6118
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.0253
AC:
1050
AN:
41566
American (AMR)
AF:
0.0740
AC:
1133
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0735
AC:
255
AN:
3470
East Asian (EAS)
AF:
0.0570
AC:
295
AN:
5176
South Asian (SAS)
AF:
0.0960
AC:
463
AN:
4824
European-Finnish (FIN)
AF:
0.141
AC:
1494
AN:
10602
Middle Eastern (MID)
AF:
0.109
AC:
32
AN:
294
European-Non Finnish (NFE)
AF:
0.108
AC:
7371
AN:
68008
Other (OTH)
AF:
0.0903
AC:
191
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
575
1149
1724
2298
2873
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
152
304
456
608
760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0942
Hom.:
139
Bravo
AF:
0.0746
Asia WGS
AF:
0.0960
AC:
335
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
1
Developmental and epileptic encephalopathy (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
1.4
DANN
Benign
0.54
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.19
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2239801; hg19: chr3-50402309; COSMIC: COSV56561717; COSMIC: COSV56561717; API